Rogo's $160M raise, Hightouch's $2.75B valuation and Teva's Tourette syndrome biotech buy
By Chelsea Naso
Published on April 29, 2026.
The article discusses several notable tech companies, including NYC-based AI platform Rogo, an AI platform for finance, raising $160m in a Series D, and Hightouch, an SF-based marketing platform, raising a $150m Series D at a $2.75b post-money valuation. Other notable companies include Axoft, a Cambridge, Mass.-based neurotechnology company, Vivacta Bio, a Shanghai-based in vivo CAR-T cell therapy biotech, and Lighthouse Pharmaceuticals, a Bay Area neurodegenerative and inflammatory disease treatment developer, raising an $12m Series A led by Double Point Ventures. German cancer biotech Tacalyx raised €11 million in a first closing of a seed extension round. The article also mentions the acquisition of Chicago-based Tourette syndrome biotech Emalex Biosciences for up to $900m. Other top tech companies include BMW i Ventures, a new $300m fund for medical innovation, as well as a $1.45b acquisition of industrial systems integrator Vertech Industries and a portfolio company for a 49.9% stake in the Illinois-based Big Sky Wind facility.
Related Articles
Tech giants double down on AI as earnings reveal growth gains and rising costs
Four tech giants, including Microsoft, Alphabet, Amazon, and Amazon, are ramping up AI spending, driven by rising costs and a shift towards digital asset diversification strategies.
Big Boy Steam Locomotive Rolls Into PA For America’s 250th: When To See It
The Big Boy Steam Locomotive will make a major stop in Philadelphia to celebrate America’s 250th anniversary, with major events and whistle stops across 10 states.
Alphabet's Q1 profit beats expectations with Google's big AI bets paying off
Alphabet's Q1 profit surged 81% to $62.6 billion, driven by strong growth in digital ads and AI investments, boosting its market value by over $1.2 trillion.